Showing results (21-30 of 157) with videos related to

Sort By:
Pageof 16
Current Opinion in Allergy and Clinical Immunology|May 6, 2004
Mediators of inflammation in the early and the late phase of allergic rhinitisInga Hansen, Ludger Klimek, Ralph Mösges, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 26, 2009
Tracheobronchoscopy and esophagoscopy in current ear-nose-throat practice: an updateHorst Schmidt, Norbert Stasche, Andreas Keller, et al.
Frontiers in Neurology|March 23, 2017
Unilateral Cochlear Implantation Reduces Tinnitus Loudness in Bimodal Hearing: A Prospective StudyJérôme J Servais, Karl Hörmann, Elisabeth Wallhäusser-Franke
Genes|May 4, 2026
Computational Mapping of Hedgehog Pathway Kinase Module Predicts Node-Specific Craniofacial PhenotypesKosi Gramatikoff, Miroslav Stoykov, Karl Hörmann, et al.
International Journal of Hygiene and Environmental Health|June 4, 2002
Evaluation of serum-free culture conditions for primary human nasal epithelial cellsCathrine Mattinger, Trang Nyugen, Dirk Schäfer, et al.
Biofactors (Oxford, England)|February 6, 2004
Expression of beta-catenin in external auditory canal cholesteatoma (EACC)Ramin Naim, Frank Riedel, Gregor Bran, et al.
Oncology Reports|February 3, 2007
Current advances in the basic research and clinical management of sinonasal inverted papilloma (review)Alexander Sauter, Rubina Matharu, Karl Hörmann, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|May 27, 2004
Ossifying haemangioma of the frontal sinusRamin Naim, Inga Steinhoff, Karl Hörmann, et al.
Advances in Oto-Rhino-Laryngology|December 21, 2004
Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapyFrank Riedel, Karl Götte, Karl Hörmann, et al.
International Archives of Allergy and Immunology|October 27, 2010
Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa studyOliver Pfaar, Christine Barth, Christine Jaschke, et al.
Pageof 16